{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:26:46Z","timestamp":1782858406796,"version":"3.54.5"},"reference-count":40,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,2,2]]},"DOI":"10.3233\/jad-150790","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T07:27:52Z","timestamp":1454916472000},"page":"895-905","source":"Crossref","is-referenced-by-count":14,"title":["The Effects of Latrepirdine on Amyloid-\u03b2 Aggregation and Toxicity"],"prefix":"10.1177","volume":"50","author":[{"given":"Tenielle","family":"Porter","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Western Australia, Australia"},{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Bharadwaj","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Western Australia, Australia"},{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Groth","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Western Australia, Australia"},{"name":"School of Psychiatry and Clinical Neuroscience, University of Western Australia, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Paxman","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Western Australia, Australia"},{"name":"School of Psychiatry and Clinical Neuroscience, University of Western Australia, Western Australia, Australia"},{"name":"The Sir James McCusker Alzheimer\u2019s Disease Research Unit, Hollywood Private Hospital, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Verdile","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Western Australia, Australia"},{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Western Australia, Australia"},{"name":"School of Psychiatry and Clinical Neuroscience, University of Western Australia, Western Australia, Australia"},{"name":"The Sir James McCusker Alzheimer\u2019s Disease Research Unit, Hollywood Private Hospital, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150790_ref1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0891988706291079","article-title":"Alzheimer\u2019s disease and the aging brain","volume":"19","author":"Terry","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-150790_ref2","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer\u2019s disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J"},{"key":"10.3233\/JAD-150790_ref3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150790_ref4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.3233\/JAD-150790_ref5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10408360903335821","article-title":"The structure and function of Alzheimer\u2019s gamma secretase enzyme complex","volume":"46","author":"Krishnaswamy","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.3233\/JAD-150790_ref6","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150790_ref7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150790_ref8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2001-3206","article-title":"The severity of cortical Alzheimer\u2019s type changes is positively correlated with increased amyloid-beta Levels: Resolubilization of amyloid-beta with transition metal ion chelators","volume":"3","author":"Fonte","year":"2001","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150790_ref9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.3233\/JAD-150790_ref10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-150790_ref11","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150790_ref12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer\u2019s disease: Clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150790_ref13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.06.018","article-title":"Discovery of a proneurogenic, neuroprotective chemical","volume":"142","author":"Pieper","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-150790_ref14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","article-title":"Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer","volume":"939","author":"Bachurin","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-150790_ref15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","article-title":"Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer\u2019s disease: A randomised, double-blind, placebo-controlled study","volume":"372","author":"Doody","year":"2008","journal-title":"Lancet"},{"key":"10.3233\/JAD-150790_ref16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2012.05.1217","article-title":"Dimebon in Alzheimer\u2019s disease: Summary and contrast of three efficacy trials","volume":"8","author":"Doody","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150790_ref17","first-page":"CD009524","article-title":"Latrepirdine for Alzheimer\u2019s disease","volume":"4","author":"Chau","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-150790_ref18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-130872","article-title":"Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: A meta-analysis","volume":"38","author":"Cano-Cuenca","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150790_ref19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.327.5971.1309","article-title":"Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer\u2019s drug","volume":"327","author":"Miller","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-150790_ref20","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1038\/tp.2013.97","article-title":"Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer\u2019s and other neurodegenerative diseases","volume":"3","author":"Bharadwaj","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-150790_ref21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12035-015-9249-4","article-title":"Novel sites of neuroprotective action of Dimebon (latrepirdine)","volume":"52","author":"Ustyugov","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-150790_ref22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/mp.2012.106","article-title":"Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer\u2019s mouse model","volume":"18","author":"Steele","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-150790_ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12640-011-9299-y","article-title":"Dimebon slows progression of proteinopathy in gamma-synuclein transgenic mice","volume":"22","author":"Bachurin","year":"2012","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-150790_ref24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/mp.2012.115","article-title":"Latrepirdine stimulates autophagy and reduces accumulation of alpha-synuclein in cells and in mouse brain","volume":"18","author":"Steele","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-150790_ref25","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.febslet.2009.06.042","article-title":"Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models","volume":"583","author":"Yamashita","year":"2009","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-150790_ref26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JAD-2012-120178","article-title":"Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast","volume":"32","author":"Bharadwaj","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150790_ref27","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","article-title":"Analysis of heterogeneous \u03b2A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay","volume":"271","author":"Ida","year":"1996","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150790_ref28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-60761-744-0_2","article-title":"Preparing synthetic Abeta in different aggregation states","volume":"670","author":"Stine","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JAD-150790_ref29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2010-100174","article-title":"Dimebon (latrepirdine) enhances mitochondrialfunction and protects neuronal cells from death","volume":"21","author":"Zhang","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150790_ref30","first-page":"115","article-title":"Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice","volume":"4","author":"Perez","year":"2012","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.3233\/JAD-150790_ref31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1017972709652","article-title":"Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels","volume":"132","author":"Lermontova","year":"2001","journal-title":"Bull Exp Biol Med"},{"key":"10.3233\/JAD-150790_ref32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1042\/BST0370692","article-title":"Inhibitors of protein aggregation and toxicity","volume":"37","author":"Amijee","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-150790_ref33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138955708784223512","article-title":"Polyphenols as potential inhibitors of amyloid aggregation and toxicity: Possible significance to Alzheimer\u2019s disease","volume":"8","author":"Bastianetto","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.3233\/JAD-150790_ref34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/psc.1416","article-title":"Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils","volume":"18","author":"Noormagi","year":"2012","journal-title":"J Pept Sci"},{"key":"10.3233\/JAD-150790_ref35","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.febslet.2008.06.021","article-title":"Serpins show structural basis for oligomer toxicity and amyloid ubiquity","volume":"582","author":"Carrell","year":"2008","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-150790_ref36","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150790_ref37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/cn200056g","article-title":"A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-beta neurotoxicity by generating nontoxic aggregates","volume":"2","author":"Wong","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-150790_ref38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/1567205011666140505094808","article-title":"Dimebon attenuates the Abeta-induced mitochondrial permeabilization","volume":"11","author":"Shevtsova","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-150790_ref39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12035-012-8271-z","article-title":"Mitochondrial dysfunction\u2013a pharmacological target in Alzheimer\u2019s disease","volume":"46","author":"Eckert","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-150790_ref40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1134\/S1607672912050079","article-title":"Dimebon activates autophagosome components in human neuroblastoma SH-SY5Y cells","volume":"446","author":"Khritankova","year":"2012","journal-title":"Dokl Biochem Biophys"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:04Z","timestamp":1777370524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":40,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-150790","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]}}}